Enzyme (MLN) Price Prediction

By CMC AI
20 May 2026 09:12AM (UTC+0)
TLDR

MLN faces immediate pressure from exchange delistings but holds speculative potential in institutional tokenized finance.

  1. Exchange Delisting (Bearish) – Binance removes MLN spot trading on May 27, 2026, reducing liquidity and likely causing sustained selling pressure as users exit positions.

  2. Tokenomics & Supply (Bearish) – Annual minting of up to 300,600 new MLN likely outpaces the fee-burn mechanism for years, creating persistent inflationary sell pressure.

  3. Adoption & Partnerships (Bullish) – Strategic deals, like with CV5 Capital and the Rayls network, could drive long-term demand if they translate into significant vault assets under management (AUM).

Deep Dive

1. Major Exchange Delisting (Bearish Impact)

Overview: Binance, the world's largest exchange, announced on May 13, 2026, that it will delist MLN, with spot trading ending on May 27, 2026 (CoinMarketCap). This followed a "Monitoring Tag" placed on the token in April 2026. The news triggered an immediate 18% price drop. Such delistings typically force holders to sell, drastically reduce trading liquidity, and damage market perception.

What this means: The loss of a top-tier trading venue severely limits MLN's accessibility for a broad investor base. Reduced liquidity often leads to higher volatility and makes it harder to execute large orders near the market price. This is a clear near-term headwind that could suppress the price until the token finds stable footing on alternative exchanges.

2. Inflationary Token Supply (Bearish Impact)

Overview: MLN's tokenomics include an annual mint of up to 300,600 new tokens for protocol development and grants. A burn mechanism destroys MLN collected as fees from vault usage. However, the project's own documentation states that "inflation is likely to exceed the amount burnt for many years to come" (Enzyme Documentation).

What this means: This structural supply dynamic means new tokens are consistently entering the market, creating sell pressure from grant recipients and developers. For the price to rise sustainably, the growth in demand from vault usage and ecosystem participation must outpace this annual inflation, which the project admits is a long-term challenge.

3. Institutional Adoption in Tokenized Finance (Bullish Impact)

Overview: Enzyme is building infrastructure for on-chain asset management. Recent partnerships, such as with CV5 Capital in November 2025 and as a launch partner for the Rayls network in May 2026, aim to bring institutional-grade tokenized funds onto its platform (Binance Square, TradingView).

What this means: If these partnerships lead to significant growth in assets managed through Enzyme vaults, it would directly increase the demand for MLN tokens used to pay protocol fees. Success in the multi-trillion-dollar tokenized asset market, as forecast by Citi, could fundamentally revalue MLN, but this is a long-term, high-conviction bet on ecosystem execution.

Conclusion

MLN's path is bifurcated: severe near-term liquidity risks from exchange exits clash with a long-term thesis on institutional DeFi adoption. A holder must weigh the likelihood of continued selling pressure against the project's ability to grow its core utility against the odds.

Will rising vault AUM finally overcome the token's inflationary design?

CMC AI can make mistakes. Not financial advice.